Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster
07:30am, Thursday, 17'th Dec 2020
SAN FRANCISCO, Dec. 17, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced all patients who undergo exome testing with Invitae will receive routine case-lev
4 Top Stock Trades for Wednesday: AMD, ACB, NVTA, SPWR
05:36pm, Tuesday, 15'th Dec 2020
Advanced Micro Devices, Aurora Cannabis, Invitae and SunPower were our top stock trades for Wednesday. Now, let's have a look at the charts.
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF
03:13pm, Monday, 14'th Dec 2020
One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.
Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer Symposium
07:30am, Wednesday, 09'th Dec 2020
SAN FRANCISCO, Dec. 9, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced three studies demonstrating the benefits of genetic testing for all breast cancer
Bull Signal Flashing For Outperforming Biotech Stock
03:14pm, Tuesday, 08'th Dec 2020
The shares of Invitae Corporation (NVTA) are up 1% at $54.73 at last check, approaching yesterday's record high of $57.12.
Invitae: Things Beyond Volume And COGS To Watch For
03:07pm, Monday, 30'th Nov 2020
Invitae loses money today but has the potential to monopolize the germline testing market. They use volume and COGS metrics to demonstrate the plausibility of their business model, but these measures
3 Innovative Stocks to Buy That Are Doing Incredible Things
01:51pm, Tuesday, 10'th Nov 2020
Investors love disruptive themes and innovation stocks. Some of those assets are already delivering massive gains to investors.
7 Data-Driven Stocks for a Wave of Innovation
01:40pm, Friday, 06'th Nov 2020
Data stocks often fly under the radar. However, investors should keep these names in mind as they power tech innovations forward.
What's Behind Invitae's Q3 Earnings Beat
06:18am, Friday, 06'th Nov 2020
The medical genetics company easily topped Wall Street's top- and bottom-line estimates in the third quarter.
Invitae Corporation. (NVTA) CEO Sean George on Q3 2020 Results - Earnings Call Transcript
12:40am, Friday, 06'th Nov 2020
Invitae Corporation. (NVTA) CEO Sean George on Q3 2020 Results - Earnings Call Transcript
Sep 28, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Preimplantation Genetic Diagnosis...
Invest In The Disruptive Innovation Future With ARK Innovation ETF (NYSEARCA:ARKK)
08:09pm, Tuesday, 22'nd Sep 2020
ARK (Active Research Knowledge) actively manages ETFs that track companies with disruptive innovation.
Heart Valve Voice US to Train Patients As Research Advisors and Advocates
12:00am, Monday, 21'st Sep 2020
Heart Valve Voice US—a patient-advocacy organization focused on improving the diagnosis, treatment, and management of heart valve disease—is pleased t
Glenmede Trust Co. NA Has $421,000 Stock Position in InVitae Corp (NYSE:NVTA)
07:40am, Saturday, 19'th Sep 2020
Glenmede Trust Co. NA boosted its stake in shares of InVitae Corp (NYSE:NVTA) by 72.7% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,926 shares of the
InVitae (NYSE:NVTA) Sets New 12-Month High at $38.05
08:00am, Thursday, 17'th Sep 2020
InVitae Corp (NYSE:NVTA) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $38.05 and last traded at $37.99, with a volume of 38158 shares trading hands. The
